Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Non-malignant and malignant meningioma incidence and survival in the elderly from 2005-2015 using the Central Brain Tumor Registry of the United States.

Achey RL, Gittleman H, Schroer J, Khanna V, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2018 Oct 6. doi: 10.1093/neuonc/noy162. [Epub ahead of print]

PMID:
30295804
2.

Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013.

Khanna V, Achey RL, Ostrom QT, Block-Beach H, Kruchko C, Barnholtz-Sloan JS, de Blank PM.

J Neurooncol. 2017 Dec;135(3):433-441. doi: 10.1007/s11060-017-2594-6. Epub 2017 Aug 21.

PMID:
28828582
3.

Descriptive Epidemiology of Spinal Meningiomas in the United States.

Kshettry VR, Hsieh JK, Ostrom QT, Kruchko C, Benzel EC, Barnholtz-Sloan JS.

Spine (Phila Pa 1976). 2015 Aug 1;40(15):E886-9. doi: 10.1097/BRS.0000000000000974.

PMID:
25996535
4.

Incidence and survival trends in oligodendrogliomas and anaplastic oligodendrogliomas in the United States from 2000 to 2013: a CBTRUS Report.

Achey RL, Khanna V, Ostrom QT, Kruchko C, Barnholtz-Sloan JS.

J Neurooncol. 2017 May;133(1):17-25. doi: 10.1007/s11060-017-2414-z. Epub 2017 Apr 10.

PMID:
28397028
5.

Italian cancer figures, report 2012: Cancer in children and adolescents.

AIRTUM Working Group; CCM; AIEOP Working Group.

Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225. English, Italian.

6.

Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States.

Kshettry VR, Ostrom QT, Kruchko C, Al-Mefty O, Barnett GH, Barnholtz-Sloan JS.

Neuro Oncol. 2015 Aug;17(8):1166-73. doi: 10.1093/neuonc/nov069. Epub 2015 May 24.

7.

Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014.

Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS.

JAMA Oncol. 2018 Sep 1;4(9):1254-1262. doi: 10.1001/jamaoncol.2018.1789.

PMID:
29931168
8.

Do race and age vary in non-malignant central nervous system tumor incidences in the United States?

Gittleman H, Cote DJ, Ostrom QT, Kruchko C, Smith TR, Claus EB, Barnholtz-Sloan JS.

J Neurooncol. 2017 Sep;134(2):269-277. doi: 10.1007/s11060-017-2543-4. Epub 2017 Jun 30.

PMID:
28667594
9.

Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis.

Stessin AM, Schwartz A, Judanin G, Pannullo SC, Boockvar JA, Schwartz TH, Stieg PE, Wernicke AG.

J Neurosurg. 2012 Oct;117(4):669-75. doi: 10.3171/2012.7.JNS111439. Epub 2012 Aug 17.

PMID:
22900840
10.

Extent of resection and overall survival for patients with atypical and malignant meningioma.

Aizer AA, Bi WL, Kandola MS, Lee EQ, Nayak L, Rinne ML, Norden AD, Beroukhim R, Reardon DA, Wen PY, Al-Mefty O, Arvold ND, Dunn IF, Alexander BM.

Cancer. 2015 Dec 15;121(24):4376-81. doi: 10.1002/cncr.29639. Epub 2015 Aug 26.

12.

Incidence rates of the primary brain tumours in Georgia--a population-based study.

Gigineishvili D, Gigineishvili T, Tsiskaridze A, Shakarishvili R.

BMC Neurol. 2014 Feb 14;14:29. doi: 10.1186/1471-2377-14-29.

13.

The effect of revised populations on mortality statistics for the United States, 2000.

Anderson RN, Arias E.

Natl Vital Stat Rep. 2003 Jun 5;51(9):1-24.

14.

Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma.

Ware ML, Larson DA, Sneed PK, Wara WW, McDermott MW.

Neurosurgery. 2004 Jan;54(1):55-63; discussion 63-4.

PMID:
14683541
15.

Adult brain cancer in the U.S. black population: a Surveillance, Epidemiology, and End Results (SEER) analysis of incidence, survival, and trends.

Gabriel A, Batey J, Capogreco J, Kimball D, Walters A, Tubbs RS, Loukas M.

Med Sci Monit. 2014 Aug 25;20:1510-7. doi: 10.12659/MSM.890762.

16.

Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994.

Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG.

Neuro Oncol. 1999 Jan;1(1):14-25. doi: 10.1093/neuonc/1.1.14.

17.

Survivorship in adults with malignant brain and other central nervous system tumor from 2000-2014.

Gittleman H, Boscia A, Ostrom QT, Truitt G, Fritz Y, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2018 Nov 9;20(suppl_7):vii6-vii16. doi: 10.1093/neuonc/noy090.

PMID:
29850889
18.

The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry.

Wöhrer A, Waldhör T, Heinzl H, Hackl M, Feichtinger J, Gruber-Mösenbacher U, Kiefer A, Maier H, Motz R, Reiner-Concin A, Richling B, Idriceanu C, Scarpatetti M, Sedivy R, Bankl HC, Stiglbauer W, Preusser M, Rössler K, Hainfellner JA.

J Neurooncol. 2009 Dec;95(3):401-411. doi: 10.1007/s11060-009-9938-9. Epub 2009 Jun 28.

PMID:
19562257
19.

Brain, other central nervous system, and eye cancer.

Polednak AP, Flannery JT.

Cancer. 1995 Jan 1;75(1 Suppl):330-7.

PMID:
8001004
20.

Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program.

Zacharia BE, Bruce SS, Goldstein H, Malone HR, Neugut AI, Bruce JN.

Neuro Oncol. 2012 Aug;14(8):1070-8. doi: 10.1093/neuonc/nos142. Epub 2012 Jun 26.

Supplemental Content

Support Center